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Cardiac Events During Competitive, Recreational, and Daily Activities
in Children and Adolescents With Long QT Syndrome
Kristina D. Chambers, BA; Virginie Beausejour Ladouceur, MD; Mark E. Alexander, MD, FHRS; Robyn J. Hylind, MS; Laura Bevilacqua, MD;
Douglas Y. Mah, MD; Vassilios Bezzerides, MD, PhD; John K. Triedman, MD, FHRS; Edward P. Walsh, MD, FHRS; Dominic J. Abrams, MD,
MRCP
Background-—The 2005 Bethesda Conference Guidelines advise patients with long QT syndrome against competitive sports. We
assessed cardiac event rates during competitive and recreational sports, and daily activities among treated long QT syndrome
patients.
Methods and Results-—Long QT syndrome patients aged ≥4 years treated with anti-adrenergic therapy were included.
Demographics included mechanism of presentation, corrected QT interval pretreatment, symptom history, medication compliance,
and administration of QT-prolonging medications. Corrected QT interval ≥550 ms or prior cardiac arrest deﬁned high risk. Sports
were categorized by cardiovascular demand per the 2005 Bethesda Conference Guidelines. Each was classiﬁed as recreational or
competitive. One hundred seventy-two patients (90; 52% female) with median age 15.2 years (interquartile range 11.4, 19.4) were
included. Evaluation was performed for family history (102; 59%), incidental ﬁnding (34; 20%), and symptoms (36; 21%). Median
corrected QT interval was 474 ms (interquartile range 446, 496) and 14 patients (8%) were deemed high risk. Treatment included
b-blockers (171; 99%), implantable cardioverter-deﬁbrillator (27; 16%), left cardiac sympathetic denervation (7; 4%), and pacemaker
(3; 2%). Sports participation was recreational (66; 38%) or competitive (106; 62%), with 92 (53%) exercising against the Bethesda
Conference Guidelines. There were no cardiac events in competitive athletes and no deaths. There were 13 cardiac events in 9
previously symptomatic patients during either recreational exercise or activities of daily life.
Conclusions-—In this cohort of appropriately managed children with long QT syndrome, cardiac event rates were low and occurred
during recreational but not competitive activities. This study further supports the need for increased assessment of arrhythmia risk
during exercise in this patient population. ( J Am Heart Assoc. 2017;6:e005445. DOI: 10.1161/JAHA.116.005445.)
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L ong QT syndrome (LQTS) is an inherited cardiacarrhythmia characterized by delayed ventricular repolar-
ization, manifest on the ECG as QT prolongation and/or
abnormal T-wave morphology.1 It has long been recognized,
even from Jervell and Lange-Nielsen’s original description, that
adrenergic stimulation (precipitated by exercise or emotion)
further delays ventricular repolarization, which is associated
with a concomitant increased risk for ventricular arrhythmias
in a genotype-speciﬁc manner.2 Anti-adrenergic therapy,
either b-blockers or cardiac sympathectomy, decreases
cardiac adrenergic stimulation, which in turn signiﬁcantly
reduces the risk of life-threatening cardiac episodes.3–5
The association between adrenergic stimulation and cardiac
events (CE) initially led to the development of guidelines
limiting individuals to low-intensity activities (ie, <7 metabolic
equivalents [METS]) irrespective of anti-adrenergic treatment.
For example, the 2005 36th Bethesda Conference Guidelines
(BCG) recommended that LQTS athletes refrain from partici-
pating in most competitive sports if they had a prior history of
symptoms attributable to LQTS, QT prolongation >470 ms in
males and >480 ms in females, or an implantable cardioverter-
deﬁbrillator (ICD).6 The European Society of Cardiology, on the
other hand, recommended avoiding competitive sports in
patients with symptoms and/or corrected QT interval (QTc)
>440 to 470 ms in males and 460 to 480 ms in females, those
with an ICD, as well as gene carriers with no phenotypic
expression.7 As acknowledged by the Bethesda Guidelines
Expert Panel, many of the conclusions were made with a “heavy
input of ‘what seems reasonable,’” noting that “decision
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making of this type is often faulty but is the best available.”6
Although exercise restriction may seem a logical approach to
minimizing the risk of ventricular arrhythmias and sudden
death, in reality this proves more difﬁcult. Using accelerom-
eters and heart rate monitors, Gow recently showed that
children and adolescents frequently exceed 7 METS during free
living activities.8 Considering the well-recognized medical,
psychological, and social beneﬁts of competitive and recre-
ational exercise, and the efﬁcacy of anti-adrenergic therapy for
a signiﬁcant proportion of patients with LQTS, the incidence of
arrhythmic events has recently been reexamined in children
and young adults with LQTS who elected to continue to engage
in competitive sports against the Bethesda guidelines. Johnson
reported only 1 CE in 331 athlete-years (0.003 event rate per
athlete-year) in 60 athletes participating contrary to both
Bethesda and European recommendations. This 1 event
occurred in a child with marked QT prolongation (QTc>550 ms)
who was noncompliant with b-blockers.9 Similarly, Aziz
reported no events in 12 patients participating contrary to
the Bethesda guidelines.10 These ﬁndings led to a revision of
the guidelines published in December 2015, allowing consid-
eration of competitive sports in an athlete with either
symptomatic or electrocardiographically manifest LQTS (ie,
QTc >470 ms in males or >480 ms in females), after
institution of treatment continued for 3 months without
symptoms and with appropriate precautionary measures.11
In this study, we examined exertional CE rates in patients
with LQTS managed at a single center; these patients
participated in competitive athletics against the 2005
Bethesda recommendations. Considering the intense nature
of many noncompetitive activities, we also examined the
event rate during recreational activities, and compared these
with the event rate during activities of daily living (ADLs).
Methods
After obtaining Institutional Review Board approval, we invited
all LQTS patients treated at Boston Children’s Hospital to
participate in an in-person or telephone follow-up interview
after informed consent had been obtained. Inclusion criteria
included age ≥4 years, a clinical diagnosis of LQTS made by a
cardiac electrophysiologist, anti-adrenergic therapy (b-block-
ers or left cardiac sympathetic denervation [LCSD]), and
regular participation in recreational or competitive exercise.
Patients excluded were those with identiﬁed genetic variants in
known LQTS disease-associated genes but with no clinical
evidence of QT prolongation on either resting or exercise ECG,
and those with clinical or genetic evidence of Timothy or
Andersen-Tawil syndromes. Genotyping of probands and family
members was performed on a clinical basis at the discretion of
the treating electrophysiologist using standard disease-spe-
ciﬁc panels performed by Clinical Laboratory Improvement
Amendments (CLIA) CLIA-approved laboratories.
All charts were retrospectively reviewed and documented
for demographic, family, and clinical history. Data recorded
included the following: age and mechanism of presentation
(deﬁned as incidental, family history, or cardiac symptoms);
genotype; symptom history; b-blocker type and dosage; LCSD;
implantable ICD; pacemaker; and QTc.
The QT interval was manually measured in leads II or V5 as
the onset of the Q wave to the end of the T wave, deﬁned as
the intersection between the T-P isoelectric line and the
downslope of the tangent of the steepest slope of the last
limb of the T wave.12 The absolute QT interval was corrected
for heart rate using Bazett’s formula. The QTc was averaged
over 3 to 5 consecutive heartbeats with steady R-R interval.
When available, the highest pretreatment QTc interval was
used for data analysis. Those who had experienced a cardiac
arrest prior to therapy and those with QTc>550 ms were
considered high-risk patients.
CE on Anti-Adrenergic Therapy
CE were deﬁned as syncope, aborted cardiac arrest, appro-
priate discharge from ICD, or sudden death in patients
Clinical Perspective
What Is New?
• Long QT syndrome has traditionally been associated with
cardiac events during exercise, leading to a restriction of
competitive activities for symptomatic patients with mani-
fest QT prolongation.
• In a cohort of appropriately treated children and young adults
with long QT syndrome, recurrent cardiac event rates were
low and occurred exclusively during recreational sports or
activities of daily living but not during competitive activities.
• The presence of prior symptoms and longer corrected QT
intervals were associated with a higher risk of recurrent
cardiac events.
What Are the Clinical Implications?
• This study adds to the growing body of literature suggesting
that competitive sports appear to carry a low risk of
recurrent cardiac events among appropriately treated
patients with long QT syndrome, further supporting a
personalized approach in those who wish to participate in
competitive sports.
• This further endorses the 2015 Bethesda Conference
Guidelines permitting patients with long QT syndrome who
are asymptomatic for >3 months on appropriate therapy to
continue participating in competitive sports despite prior
symptoms or manifest QT prolongation.
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managed with anti-adrenergic therapy (b-blockers or LCSD).
Syncopal events were subdivided into “arrhythmic syncope”
or “syncope of unknown etiology.” “Arrhythmic syncope” was
deﬁned as a sudden and unexpected loss of consciousness
proven or believed by the managing physician to be arrhyth-
mic in origin, while “syncope of unknown etiology” was
deﬁned as loss of consciousness without a clear arrhythmic
etiology, but still concerning enough to warrant a therapy
change. All syncopal episodes considered vasovagal and that
did not lead to therapy modiﬁcation were excluded. In the
event of ICD therapies, telemetry was reviewed to assess the
nature of the event and deﬁned as appropriate (resulting from
ventricular tachycardia or ﬁbrillation) or inappropriate (result-
ing from supraventricular tachycardia, device or lead failure).
For those with CE, the following information was retrospec-
tively recorded and/or obtained during questionnaire inter-
view (as described below): age, activity (competitive,
recreational, or ADL); b-blocker type and compliance for
3 days prior; administration of QT-prolonging medications in
the 24 hours preceding a CE; and subsequent therapy
changes.
Exercise and Sports
In addition to the medical history review, patients received a
questionnaire about their exercise history. Prior to completing
the questionnaire, patients were advised that this would not
be included in their medical record and patient-speciﬁc
information would not be fed back to their primary
electrophysiologist. All interviews were conducted by a
single investigator (KC) who was not involved with clinical
management.
Each sport/exercise was classiﬁed by cardiovascular
demand, as determined by the BCG to be low (class 1A),
low-moderate (class 2A, 1B), moderate (class 3A, 2B, 1C),
high-moderate (class 3B, 2C), or high (class 3C, Figure).13
Sports unclassiﬁed by the BCG were assigned a classiﬁcation
based on the static (power) and dynamic (endurance)
component. As such, yoga and marching band were classiﬁed
as 1A, cheerleading and dance as 3A, and kickball as 2B. To
fully capture exercise participation, we added the category of
“child’s play” for those whose primary exercise was general
play (running, jumping, etc). Because of the wide variability in
child’s play, we labeled it as “recreational activity,” but did not
assign it a Bethesda sport classiﬁcation.
Patients answered further questions about the sport with
greatest cardiovascular demand. If a patient participated in 2
sports with similar cardiovascular demand (eg, 2 high-
moderate sports), we used the sport played most frequently
for analysis. For the maximal sport, patients indicated
whether participation was recreational (without regular train-
ing or competition) or competitive (with regular training and
Figure. Classiﬁcation of sports. A, Example of sports classi-
ﬁed as combination of published static component (Class I–III)
and dynamic component (Class A–C). Note that increasing
static component is related to the estimated percent of
maximal voluntary contraction (MVC) reached, resulting in an
increasing blood pressure load, while increasing dynamic
component is deﬁned in terms of the estimated percent of
maximal oxygen uptake (MaxO2) achieved, resulting in an
increasing cardiac output. Adapted with permission from the
2005 AHA/ACC Eligibility and Disqualiﬁcation Recommenda-
tions for Competitive Athletes with Cardiovascular Abnormal-
ities.13 B, Classiﬁcation of the primary sports for all patients
who chose to remain active based upon the highest compo-
nent sport they participate in. C, Classiﬁcation of sports for
those patients exercising against Bethesda recommendations.
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competition). They also indicated their intensity level, deﬁned
by level of perspiration and respiratory effort as low (minimal
perspiration/slightly above normal breathing), moderate (def-
inite perspiration/above normal breathing), or heavy (heavy
perspiration/heavy breathing).14 Finally, patients indicated
whether LQTS had inﬂuenced their participation in athletics.
Bethesda Conference Guidelines (BCG)
While guidelines exist for recreational sport participation for
LQTS patients,15 because of the often intense nature of
recreational activities and to create a degree of uniformity,
recreational sports were also classiﬁed as per the 2005 BCG
recommendations. Moreover, the 2005 BCG guidelines were
used to design this study because the 2015 American Heart
Association/American College of Cardiology guidelines on
LQTS sport participation were not yet published.
Therefore, patients were considered to participate against
the 2005 BCG if they were active in either competitive or
recreational sports higher than classiﬁcation 1A and if they:
were male with a QTc≥470 ms or female with a QTc≥480 ms;
and/or had a prior history of cardiac arrest or arrhythmic
syncope; and/or had an implantable ICD. Competitive swim-
mers with KCNQ1 mutations considered disease-causing were
considered to compete against the BCG irrespective of QTc
interval.
Statistical Analysis
Study data were collected and managed using REDCap
electronic data capture tools hosted at Boston Children’s
Hospital. Statistical analysis was performed using STATA
version 13.1 (College Station, TX). Categorical variables are
presented as number of patients and percentage. Continuous
variables are presented as median and interquartile range
(IQR) (25%, 75%). Differences in age and QTc and competitive
or recreational participation according to long QT genotype
were assessed using analysis of variance and t test,
respectively. Differences in sex and symptoms by long QT
genotype and participation were assessed using a v2 analysis.
The t test was used to determine the difference in QTc in
those participating within and against BCG. Spearman’s rank
correlation was used for the comparison between perceived
exertion and BCG classiﬁcation. Breakthrough CE were
assessed using Kruskal–Wallis test for continuous variables
and Fisher exact test for categorical variables.
Results
The case records of 276 patients in the Boston Children’s
Hospital LQTS database were reviewed, of whom 104 were
not included on the basis of age <4 years (25), no partici-
pation in competitive or recreational activities (19), declined
study participation, no response to questionnaire or inade-
quate information (53), patients with disease-associated gene
variants but no identiﬁable phenotype (4), and other condi-
tions: Timothy syndrome (1), Andersen-Tawil (1) and triadin
knockout syndrome (1).16 In the 19 patients who responded
but actively avoided activities, the median QTc was 460 ms
(IQR 442, 469), of whom 2 were symptomatic prior to
diagnosis, both with QTc intervals >500 ms (504 and
521 ms). Therefore, 172 eligible patients followed between
January 1990 and May 2015 were included (Table 1).
The median age at time of study was 15.2 years (IQR 11.4,
19.4; range 4.0–46.3). Patients had a median QTc of 474 ms
(IQR 446, 496) and were followed for a median of 7.1 years
(IQR 3.5, 9.2). There was no difference in the median QTc
between the study group and the 19 patients who responded
and avoided exercise. The cohort included 90 females, 67
probands, and 14 high-risk patients. All patients were
receiving anti-adrenergic therapy, in the form of b-blocker
therapy (171; 99%) or LCSD (1; 1%). In addition, 26 patients
(15%) received implantable cardioverter-deﬁbrillators, 3
patients (2%) received permanent pacemakers, and 6 patients
(3%) underwent LCSD in addition to b-blockers. Those on
b-blocker therapy were primarily prescribed the nonselective
b-blockers, nadolol or propranolol, at 0.63 mg/kg per day
Table 1. Clinical Characteristics of Study Patients
Demographics Total=172
Sex (female/male) 90/82
Age at diagnosis, y* 9.0 (3.0, 13.0; range 0.08–37)
Age at study, y* 15.2 (11.4, 19.4; range 4.0–46.3)
QTc, ms* 474 (446, 496)
Treatment
b-Blocker only, n 142 (83%)
b-Blocker & ICD, n 20 (12%)
b-Blocker & PPM, n 3 (2%)
b-Blocker & LCSD & ICD, n 6 (3%)
LCSD & ICD, n 1 (1%)
Diagnostic mechanism
Family screening, n 102 (59%)
Incidental findings, n 34 (20%)
Syncope, n 33 (19%)
Cardiac arrest, n 3 (2%)
ICD indicates implantable cardioverter-deﬁbrillator; LCSD, left cardiac sympathetic
denervation; PPM, permanent pacemaker; QTc, corrected QT interval.
*Values listed represent median (interquartile range; range).
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(0.38, 0.87) and 1.57 mg/kg per day (0.87, 2.91), respec-
tively (Table 2).
One hundred forty patients (81%) had an identiﬁable
mutation in 1 of the LQTS susceptibility genes, with KCNQ1
(82; 59%), KCNH2 (40; 29%), SCN5A (7; 5%), and compound
mutations (8; 6%), representing the largest subsets.
Exercise and Sports
Patients exercised on a recreational (66; 38%) or competitive
(106; 62%) basis. There were no signiﬁcant differences
between the recreational and competitive group by QTc, prior
symptom history (syncope, cardiac arrest), LQTS type, or sex
(P>0.05); however, those in the competitive group were older
(P<0.001) (Table 3).
Patients participated mostly in moderate (class 1C, 2B, or
3A) or high-moderate (3B or 2C) sports (Figure). Where
possible, each participant recorded his or her perceived
intensity level as light (14; 19%), moderate (24; 34%), or heavy
(34; 47%). When comparing patient-perceived exertion with
BCG-classiﬁed exertion level, we observed overall good
agreement between the 2 methods (Spearman r=0.69). There
was no signiﬁcant difference in median (IQR) QTc interval
related to patient-perceived intensity level; light 481 ms
(477–504); moderate 477 (445–507); heavy 482 ms (455–
497) (P=0.23), although those with prior symptoms were
more likely to undertake a lighter intensity level of activity
(light 44%; moderate 15%; heavy 13%) (P=0.01).
Out of 72 respondents asked if a diagnosis of LQTS had
inﬂuenced them to stop or not take up a speciﬁc sport, 37
(51%) replied no and 35 (49%) replied yes. There was no
signiﬁcant difference between the 2 groups in terms of QTc
interval (477 ms [454–491] versus 478 ms [451–499],
P=0.85) or prior symptoms (16% versus 26%, P=0.32).
Bethesda Conference Guidelines (BCG)
Ninety-two patients (53%; 47 female) participated in sports
against the BCG on a recreational (33) or competitive (59)
basis, primarily in high-moderate sports (Figure), including 50
probands, and 12 high-risk individuals, with a median age of
15.5 years (11.9, 20.7) and follow-up of 7.2 years (3.4, 11.3).
Only 1 patient with a KCNQ1 mutation (long QT1) and normal
QT interval (QTc 451 ms) was involved in competitive
swimming. Those who participated in athletics against BCG
had a longer QTc than those who participated in accordance
with guidelines (491 ms [474, 513] versus 447 [436, 459],
P<0.05).
Table 3. Baseline Demographic Variables and Prior Symptoms by Genotype and Athletic Participation
KCNQ1 KCNH2 SCN5A Multiple P Value Competitive Recreational P Value
Number 82 40 7 8 106 66
Age, y 15.8 (11.6, 20.4) 14.2 (9.7, 17.5) 12.4 (10.7, 15.8) 14.3 (13.5, 16.9) 0.26 16.3 (12.8, 19.8) 12.8 (8.0, 17.3) 0.0003
QTc, ms 455 (443, 488) 476 (448, 516) 461 (443, 498) 496 (460, 549) 0.006 466 (443, 501) 472 (447, 489) 0.84
Sex (female) 39 21 3 5 0.82 60 30 0.16
Asymptomatic 64 32 4 3 0.04 32 17 0.32
Prior symptom:
Syncope 18 7 3 5 0.03 27 11 0.18
Cardiac arrest* 0 1 0 0 0.49 1 2 0.31
KCNQ1 50 32 0.28
KCNH2 27 13 0.84
SCN5A 6 1 0.42
Multiple 6 2 0.71
LQTS indicates long QT syndrome; QTc, corrected QT interval.
*Please note that a total of 3 cardiac arrests occurred in the cohort prior to LQTS diagnosis, 2 of which occurred in genotype-negative patients. Values are listed as number or median
(interquartile range) as appropriate.
Table 2. b-Blocker Therapy
Agent Number Dose, mg* Dose, mg/kg Per Day*
Nonselective
Nadolol 106 30 (20, 40) 0.63 (0.39, 0.87)
Propranolol 7 60 (30, 72) 1.57 (0.87, 2.91)
Selective
Atenolol 15 37.5 (25, 50) 0.58 (0.46, 1.15)
Betaxolol 31 7.5 (5, 10) 0.16 (0.10, 0.20)
Bisoprolol 7 5 (5, 10) 0.10 (0.08, 0.15)
Metoprolol 6 25 (12.5, 25) 0.34 (0.34, 0.42)
*Values listed represent median (interquartile range).
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Cardiac Events
In a combined 1203 years of patient follow-up, there were 13
CE in 9 patients (Tables 4 and 5), 8 of whom were
symptomatic prior to their diagnosis of LQTS, and had
signiﬁcantly longer QT intervals than those patients who
remained asymptomatic (Table 6). Four events occurred
during recreational exercise and 9 during ADL. There were
no deaths.
CE During Exercise
There were no syncopal events reported during competitive
exercise, and no cardiac arrests or deaths during either
Table 4. CE During Recreational Activities
Patient Sex QTc, ms*
Initial
Symptom Genotype
Age,
y
Exercise
(Bethesda class)† QT+Rx‡ b-Blocker ICD Outcome
#1 Male 507 Exertional
syncope
KCNQ1 15 Skateboarding
(IIIB)
No Nadolol
(compliant)
No ICD implanted
#2 Male 498 Exertional
cardiac
arrest
Negative 12 Long distance
running (1C)
No Nadolol
(compliance
unknown)
Yes—ICD
shock
Increased
BB dose
#3§ Female 500 Exertional
syncope
Negative 10 Child’s play No Atenolol
(compliant)
No ICD implanted;
BB changed
#4 Male 528 Exertional
syncope
KCNQ1 10 Child’s play No Nadolol
(compliance
unknown)
No ICD implanted
BB indicates b-blocker; CE, cardiac events; ICD, implantable cardioverter-deﬁbrillator.
*Highest pretreatment corrected QT interval reported.
†Reported exercise at the time of cardiac event.
‡QT+Rx, QT-prolonging medications.
§Patient #3 is the same as patient #1 in Table 5.
Table 5. CE During ADL
Patient Sex
QTc,
ms*
Initial
Symptom Genotype
Age,
y Activity† QT+Rx‡ b-Blocker ICD Outcome
#1§ Female 500 Exertional
syncope
Negative 10 Walking in a
winter storm
No Nadolol (compliant) Yes—3 shocks
for TdP
Mexiletine added
#2 Female 513 Syncope KCNH2 17 Walking No Nadolol/labetalol
(compliant)
No ICD implanted
18 Auditory
stimulation
No Nadolol/labetalol
(compliant)
Yes—1 shock
for TdP
BB dose increased
#3 Female 450 Syncope KCNQ1 23 Using copy
machine
No BB unknown
(noncompliant)
No ICD implanted
#4 Female 590 Syncope KCNH2 14 Giving speech
at school
No Nadolol (compliance
unknown)
Yes—TdP
self-terminated
Mexiletine added
#5 Female 585 Syncope KCNQ1 4 Shopping Unknown Atenolol
(noncompliant)
Yes—TdP storm||
with ICD shock
Change BB
5 Using bathroom Unknown Nadolol (compliance
unknown)
Yes—TdP storm
with ICD shock
LCSD
#6 Male 553 TdP during
surgery
KCNH2 7 Running from
car to garage
No Propranolol
(compliant)
Yes—TdP storm
with ICD shock
Changed BB
8 Post ICD revision No Atenolol (compliant) Yes—TdP storm
with ICD shock
Changed BB
ADL indicates activities of daily living; BB, b-blocker; CE, cardiac events; ICD, implantable cardioverter-deﬁbrillator; LCSD, left cardiac sympathetic denervation; QTc, corrected QT interval;
TdP, torsades des pointes.
*Highest pretreatment QTc reported.
†Reported activity at the time of cardiac event.
‡QT+Rx, QT prolonging medications.
§Patient #1 is the same as patient #3 in Table 4.
||TdP storm deﬁned as 3 or more ICD therapies within a 24-h period.
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recreational or competitive exercise. Four patients experienced
a single episode of syncope during recreational exercise, which
in 1 case led to an appropriate ICD therapy. All 4 patients
participated in sports categorized >1A, and 1 patient was
considered high risk (by virtue of prior cardiac arrest). One event
occurred during skateboarding (high-moderate), 1 during long-
distance running (moderate), and 2 during child’s play (Table 4).
In 2 patients, b-blocker compliance was conﬁrmed and in the
other 2, this was unknown. None of the 4 patients had received
QT-prolonging medications.
CE During ADL
Six patients (3 high risk by virtue of QTc>550 ms) experi-
enced 9 CE during ADL (Table 5). Patients were compliant
with b-blockers on 5 occasions, noncompliant on 2 occasions,
and unknown on 2. No event occurred within 24 hours of
taking known QT-prolonging medications, although 1 patient
was receiving an unknown antibiotic.
Discussion
This single-center study provides further documentation of the
rate of CE in an appropriately managed cohort of patients with
LQTS. None of the 59 patients who continued to participate
competitively had a CE. Four episodes of arrhythmic syncope
occurred during recreational activity (including 2 during child’s
play) and a further 9 episodes during ADL. All those who had
symptoms on anti-adrenergic therapy were symptomatic prior
to treatment, which has important implications for the ever-
increasing number of asymptomatic patients diagnosed by
clinical or genetic cascade familial screening. These data
support that of Johnson9 and Aziz10 in describing event rates
signiﬁcantly lower than initially anticipated, and enhances the
notion that many appropriately counseled and managed
children and young adults with LQTS choose to continue
competitive activities, and do so safely. These ﬁndings have
been reﬂected in the most recent Bethesda guidelines
published in 2015, permitting symptomatic patients with
LQTS who are asymptomatic for >3 months on appropriate
therapy to continue participating competitively despite prior
symptoms or manifest QT prolongation. Fundamental to such
an approach, however, is the understanding from the whole
family that a small but undeﬁnable risk persists, that
medication compliance and avoidance of QT-prolonging
agents is mandatory, and that coaches and school staff
accept the athlete’s participation and that the appropriate
resuscitation equipment and those trained in its use are
present during sporting activities.
CE During Exercise
While fully respecting the importance of the BCG, our
institutional approach was to allow appropriately managed
and counseled patients to continue activities following a
diagnosis of long QT syndrome, with 59 patients participating
in regular competitive exercise against the recommendation
of the Bethesda guidelines, and 33 continuing in recreational
activities. Of those who regularly exercised, only 3 partici-
pated in approved class 1A sports; instead, most were
involved in activities requiring moderate or high-moderate
cardiovascular demand. Even though most patients partici-
pated in competitive sports, which are commonly presumed
to be more demanding and intense, all 4 of the exercise-
precipitated syncopal events occurred during recreational
activities. Although this may suggest recreational and com-
petitive activities may be equally intense, it is of course
possible that these individuals were of higher risk by virtue of
Table 6. CE During Daily Living and Recreational Activities
No CE
CE
During ADL
CE During
Recreational Sports P Value
Number 163 6 4
Age at diagnosis, y* 9 (3, 13) 8 (5, 10) 8 (7, 10) 0.97
Prior symptoms 20% 83% 100% <0.01
QTc, ms* 466 (445, 494) 533 (468, 577) 503 (487, 512) 0.03
Genotype 0.52
KCNQ1 50% 17% 50%
KCNH2 22% 33% 
SCN5A 4%  
Multiple 4% 17% 
Negative/unknown 20% 33% 50%
ADL indicates activities of daily living; CE, cardiac events; QTc, corrected QT interval.
*Values listed represent median (interquartile range).
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prior symptomatic presentation and therefore limited them-
selves by choice. Similarly, a number of patients at potentially
higher risk may have decided to not participate in any
activities, thereby invoking an element of selection bias, and
67 patients in our institutional cohort were excluded from the
study on that basis.
The Bethesda guidelines restricted competitive athletes
under the reasonable assumption that competitive sports are
more intense and therefore confer greater cardiac risk;
however, the relationship between intensity and cardiac risk
in appropriately managed LQTS patients remains unclear.
Deﬁning causality between levels of intensity and arrhythmic
risk is challenging given the signiﬁcant personal variability in
different genetic, phenotypic, and environmental factors, and
makes it challenging to use “intensity levels” to design
exercise restrictions. Depending on motivation, skill level, and
sport type, what is recreational for 1 patient may be intensely
competitive for another.
CE During ADL
During daily activities, children and adolescents frequently
exceed the 7 METS limit set by BCG/ESC.8 In this study, there
were 9 CE during ADL: 8 occurred during activities requiring <7
METS (walking to class, using the copy machine, etc) and 1
occurred during an activity requiring >7 METS (walking
vigorously through a snowstorm). Overall, therefore, the 8
CE during daily activities are only marginally greater than the 5
events reported during exercise. It is estimated that children
and adolescents spend90% of time performing activities that
require <7 METS energy expenditure.8 Therefore, the propor-
tional event rate may be signiﬁcantly higher in this experience
during exercise and more exertional daily activities. Children
typically spend 4% of their day (7 hours/week) engaged in
exertional activities,17 and a further 2.3% above the 7 MET
threshold daily activities. Based on our follow-up of 1203
patient-years, this translates approximately to 49 patient-
years follow-up during exercise, 28 patient-years follow-up
during ADL>7 METS, and 1143 patient-years follow-up during
ADL<7 METS. As such the proportional CE rates are highest
during exercise 0.08 events/year (although none during
competitive exercise), compared with 0.04 and 0.007
events/year during ADL of >7 and <7 METS, respectively.
This again may reﬂect the speciﬁc risk proﬁle of the individual
patients, although limiting children and adolescents from
child’s play or walking in a storm would prove very challenging.
Comparative CE Rates
CE rates in this experience were similar to those recently
reported during competitive exercise. In a study published in
2013, Johnson reported an event rate of 0.003 event/year
among 60 athletes participating contrary to both the
Bethesda and European recommendations,9 while Aziz in
2015 reported no events in 12 patients participating contrary
to the Bethesda guidelines.10 Overall, these CE rates are
signiﬁcantly lower than that previously published,18,19 which
may be explained in a number of different ways.
Firstly, a large proportion of this cohort (67%) was asymp-
tomatic when diagnosed with LQTS, identiﬁed through family
screening or because of an incidental electrocardiographic
ﬁnding of QT prolongation. Increasingly, evidence suggests
those who are asymptomatic at diagnosis remain so once
started on appropriate b-blockers3,20. The increasing recogni-
tion of LQTS in the medical community and the implementation
of familial screening means that many are diagnosed prior to
the onset of symptoms, compared with prior eras when more
than half of patients were diagnosed following a symptomatic
event.3,18,19,21 Secondly, and closely associated with the
above, the overall QTc intervals reported here are shorter than
prior studies, whose average QTc range up to 520 ms.
Therefore, there is a higher proportion of asymptomatic
patients in this category with overall less QT prolongation,
suggesting an overall lower risk proﬁle when compared with
historical cohorts. Finally, we attempted to differentiate
between different syncopal events, excluding those not
considered to be arrhythmic in nature, which may further
reduce the measured event rate. Given the very high
incidence of benign syncope in teenage life affecting 50% of
females and 20% of males,22 we included only events
considered to be arrhythmic at the time by the managing
physician.
Limitations
With this observational single-center retrospective study, we
were limited to data from medical records and from follow-up
interviews, which may introduce recall bias. Importantly, as
already mentioned, a signiﬁcant proportion of patients man-
aged in this institution were not involved in either recreational
or sporting activities, whichmay represent self-exclusion based
on a higher risk proﬁle, and therefore not be truly representative
of the entire experience of CE occurring during activities of daily
life. Moreover, we did not describe CE for patients exercising off
anti-adrenergic therapy because almost all patients at Boston
Children’s Hospital are managed with anti-adrenergic therapy.
In addition, there are a number of sports in the study that were
poorly represented. Accordingly, we did not risk assess
different sports and sport levels. Results should not be
extrapolated to all sports and competition levels. Finally, with
an overall low CE rate in this cohort, the current analysis may
have lacked adequate power to examine differences in CE rates
based on compliance with exercise restriction. The results
nevertheless add to others in the literature, which have
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observed similar ﬁndings9,10 and taken together, support a
growing body of literature in this ﬁeld.
Conclusions
In 1203 years of patient follow-up, we report a low CE rate
among appropriately managed patients with LQTS. Impor-
tantly, there were no events during competitive athletics in
the 59 patients who elected to continue against the 2005
Bethesda guidelines. All events occurred during recreational
athletics or activities of daily life.
While the CE rate during exercise is proportionally greater
than during ADL, the event rate during exercise is still very
low. Our CE rate during exercise reﬂects data published from
other institutions9,10 and further supports the importance of
patient and family choice coupled with expert counseling in
decisions regarding the continuation of sporting activities.
While it is necessary to account for risks during exercise, it is
still important to recognize the positive social, emotional, and
health beneﬁts of a regular exercise program. We believe
LQTS patients seeking an active lifestyle should be provided
with appropriate data and counseling to balance the relative
risks and beneﬁts of continued participation. The ongoing
National Institutes of Health funded prospective study to
determine how lifestyle and exercise impact the well-being of
individuals with LQTS (www.livelqts.org) will undoubtedly
provide further information on the safety and beneﬁt of
sporting activities in patients with long QT syndrome.
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